FR2358155A1 - Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses - Google Patents

Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses

Info

Publication number
FR2358155A1
FR2358155A1 FR7720737A FR7720737A FR2358155A1 FR 2358155 A1 FR2358155 A1 FR 2358155A1 FR 7720737 A FR7720737 A FR 7720737A FR 7720737 A FR7720737 A FR 7720737A FR 2358155 A1 FR2358155 A1 FR 2358155A1
Authority
FR
France
Prior art keywords
eye
skin
treatment
mucosauses
irritation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7720737A
Other languages
English (en)
French (fr)
Other versions
FR2358155B1 (cg-RX-API-DMAC7.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB2942176A external-priority patent/GB1561037A/en
Application filed by Individual filed Critical Individual
Publication of FR2358155A1 publication Critical patent/FR2358155A1/fr
Application granted granted Critical
Publication of FR2358155B1 publication Critical patent/FR2358155B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FR7720737A 1976-07-15 1977-07-06 Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses Granted FR2358155A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2942176A GB1561037A (en) 1976-07-15 1976-07-15 Composition for the treatment and prevention of skin eye and mucosal inflammation
GB1967877 1977-05-11

Publications (2)

Publication Number Publication Date
FR2358155A1 true FR2358155A1 (fr) 1978-02-10
FR2358155B1 FR2358155B1 (cg-RX-API-DMAC7.html) 1980-02-01

Family

ID=26254187

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7720737A Granted FR2358155A1 (fr) 1976-07-15 1977-07-06 Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses

Country Status (3)

Country Link
US (1) US4208406A (cg-RX-API-DMAC7.html)
DE (1) DE2732179A1 (cg-RX-API-DMAC7.html)
FR (1) FR2358155A1 (cg-RX-API-DMAC7.html)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127160A1 (de) * 1983-05-27 1984-12-05 Gödecke Aktiengesellschaft Äusserlich anzuwendende Arzneimittelzubereitung enthaltend Adenosin zur Behandlung von Herpes
EP0234854A3 (en) * 1986-02-19 1987-11-19 Eye Research Institute Of The Retina Foundation Preparations for stimulation of tear secrtetion with phosphodiesterase inhibitors and cyclic nucleotideanalogues
EP0249873A3 (en) * 1986-06-16 1990-01-10 Daiichi Seiyaku Co. Ltd. Therapeutic agent for skin ulcers
EP0335379A3 (en) * 1988-03-30 1990-01-10 Daiichi Seiyaku Co. Ltd. Cyclic amp derivative ointments
US4956348A (en) * 1986-02-19 1990-09-11 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with cyclic nucleotides
WO1991000726A1 (fr) * 1989-07-13 1991-01-24 Parfums Christian Dior UTILISATION D'AMPc OU SES DERIVES POUR LA PREPARATION DE COMPOSITIONS COSMETIQUE OU PHARMACEUTIQUE
EP0553790A1 (en) * 1992-01-27 1993-08-04 Daiichi Pharmaceutical Co., Ltd. Cyclic amp derivative-containing ointment

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2949217C2 (de) * 1979-12-07 1984-03-01 Jörn Prof. Dr. 2072 Jersbek Bethge Arzneimittel mit Callusbildung und Wundheilung fördernder Wirkung
US4369181A (en) * 1981-08-05 1983-01-18 Sri International Process for treating proliferative skin diseases using certain 6,8-substituted ribofuranosylpurine-3',5'-cyclic phosphates
FR2518882A1 (fr) * 1981-12-30 1983-07-01 Pos Lab Composition therapeutique, a base de monophosphate d'inosine, pour le traitement des troubles d'accommodation de l'oeil
US5783591A (en) * 1984-10-19 1998-07-21 Schering Aktiengesellschaft Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation
US5376643A (en) * 1986-09-18 1994-12-27 Lion Corporation Composition for application to hair
US6919320B1 (en) 1987-10-28 2005-07-19 Wellstat Therapeutics Corporation Pharmaceutical compositions containing deoxyribonucleosides for wound healing
US6348451B1 (en) 1987-10-28 2002-02-19 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
US6020322A (en) * 1993-11-09 2000-02-01 Pro-Neuron, Inc. Acyl deoxyribonucleoside derivatives and uses thereof
US6743782B1 (en) 1987-10-28 2004-06-01 Wellstat Therapeutics Corporation Acyl deoxyribonucleoside derivatives and uses thereof
ATE243039T1 (de) * 1987-10-28 2003-07-15 Wellstat Therapeutics Corp Acyldeoxyribonukleosid-derivate und verwendungen davon
ZA892928B (en) * 1988-04-25 1991-01-30 Pro Neuron Inc Pharmaceutical compositions containing deoxyribonucleosides for wound healing
WO1989011487A1 (en) * 1988-05-23 1989-11-30 United States Of America, Represented By The Secre Derivatives of cyclic amp as treatment for cancer
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
US7169765B1 (en) 1988-10-27 2007-01-30 Wellstat Therapeutics Corporation Acyl deoxyribonucleoside derivatives and uses thereof
US6033665A (en) * 1989-09-27 2000-03-07 Elan Pharmaceuticals, Inc. Compositions and methods for modulating leukocyte adhesion to brain endothelial cells
US5260210A (en) * 1989-09-27 1993-11-09 Rubin Lee L Blood-brain barrier model
US5185150A (en) * 1990-08-24 1993-02-09 Wisconsin Alumni Research Fdn. Cosmetic compositions containing 19-nor-vitamin D compounds
WO1993021929A1 (en) * 1992-05-01 1993-11-11 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Phosphorothioate derivatives of cyclic amp analogues
ZA961081B (en) * 1995-02-10 1996-10-15 Schering Ag Pharmaceutical preparations for tnf inhibition
DE19540475A1 (de) * 1995-10-20 1997-04-24 Schering Ag Chirale Methylphenyloxazolidinone
US6531140B2 (en) * 1999-05-04 2003-03-11 E-L Management Anti-irritant compositions containing a cyclic nucleotide
US20030026794A1 (en) * 2001-07-31 2003-02-06 Howard Fein Selective enzyme treatment of skin conditions
GB0501476D0 (en) * 2005-01-25 2005-03-02 Heptagen Ltd Treatment for mucositis
WO2007006544A2 (en) * 2005-07-12 2007-01-18 Vrije Universiteit Brussel Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2258860A1 (cg-RX-API-DMAC7.html) * 1972-07-10 1975-08-22 Nelson Res & Dev

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1336441A (en) * 1969-10-10 1973-11-07 Anvar Derivatives of cyclo adenosine-3,5-phosphoric acid and their preparation
JPS497414A (cg-RX-API-DMAC7.html) * 1972-05-24 1974-01-23

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2258860A1 (cg-RX-API-DMAC7.html) * 1972-07-10 1975-08-22 Nelson Res & Dev

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127160A1 (de) * 1983-05-27 1984-12-05 Gödecke Aktiengesellschaft Äusserlich anzuwendende Arzneimittelzubereitung enthaltend Adenosin zur Behandlung von Herpes
EP0234854A3 (en) * 1986-02-19 1987-11-19 Eye Research Institute Of The Retina Foundation Preparations for stimulation of tear secrtetion with phosphodiesterase inhibitors and cyclic nucleotideanalogues
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
US4956348A (en) * 1986-02-19 1990-09-11 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with cyclic nucleotides
EP0249873A3 (en) * 1986-06-16 1990-01-10 Daiichi Seiyaku Co. Ltd. Therapeutic agent for skin ulcers
EP0335379A3 (en) * 1988-03-30 1990-01-10 Daiichi Seiyaku Co. Ltd. Cyclic amp derivative ointments
US5096891A (en) * 1988-03-30 1992-03-17 Daiichi Seiyaku Co., Ltd. Cyclic amp derivative ointments
WO1991000726A1 (fr) * 1989-07-13 1991-01-24 Parfums Christian Dior UTILISATION D'AMPc OU SES DERIVES POUR LA PREPARATION DE COMPOSITIONS COSMETIQUE OU PHARMACEUTIQUE
EP0553790A1 (en) * 1992-01-27 1993-08-04 Daiichi Pharmaceutical Co., Ltd. Cyclic amp derivative-containing ointment

Also Published As

Publication number Publication date
FR2358155B1 (cg-RX-API-DMAC7.html) 1980-02-01
DE2732179A1 (de) 1978-01-19
US4208406A (en) 1980-06-17

Similar Documents

Publication Publication Date Title
FR2358155A1 (fr) Composition pour le traitement et la prevention de l'irritation et de l'inflammation de la peau, de l'oeil et des muqueuses
DE69316660D1 (de) Terfanadin Metaboliten und deren optisch reine Isomere zur Behandlung von allergischen Krankheiten
FR2356424A1 (fr) Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales
FR2416216A1 (fr) Nouvelles acyl anilines et leur application fongicide
FR2430410A1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
CA1333179C (en) Method and compounds for reducing dermal inflammations
ES2040242T3 (es) Composiciones farmaceuticas.
FR2445146A1 (fr) Medicament a prise orale contenant une substance inhibitrice de l'inflammation et un ou plusieurs phospholipides
KR880000091A (ko) 국소용 약제학적 조성물 이의 제조방법 및 이의 용도
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
BE904421A (fr) Derives heterocycliques aromatiques et leur application dans les domaines therapeutique et cosmetique.
DE3766322D1 (de) Waessrige loesung fuer die augen zur behandlung der trockenheit u/o der reizung von menschlichen oder tierischen augen.
ATE45941T1 (de) Medizinische zusammensetzung zur behandlung von allergie-krankheiten.
FR2391723A1 (fr) Composition therapeutique a base de cetone aliphatique pour le traitement des ulceres peptiques
ATE15596T1 (de) Pharmazeutische mittel.
SE8703066L (sv) Antiseptisk komposition innehallande etylalkohol och monolaurin
FR2404634A1 (fr) Composes de thiazole et compositions pharmaceutiques en contenant
FR2432519A1 (fr) Nouveaux derives de purine et medicament les contenant
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
FR2393577A1 (fr) Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse
FR2420344A1 (fr) Nouveaux oxime-ethers, leur preparation et leur application therapeutique.
FR2393579A1 (fr) Agent antiviral et son application au traitement des affections virales
FR2447189A1 (fr) Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant en tant que composes actifs des alkylene-dithioethers
FR2428436A1 (fr) Nouvelles compositions cosmetiques pour le traitement de l'etat gras des cheveux et de la peau, composes nouveaux et leur procede de preparation
FR2388789A1 (fr) Derives d'acide benzoique, leur procede de preparation et leur application therapeutique

Legal Events

Date Code Title Description
MD Transfer of rights in case of death
TP Transmission of property
TP Transmission of property
ST Notification of lapse